Status:
COMPLETED
Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections
Lead Sponsor:
Cheng-Hsin General Hospital
Conditions:
Chronic Stroke
Spasticity as Sequela of Stroke
Eligibility:
All Genders
20-85 years
Phase:
PHASE2
Brief Summary
Over fifty percent of stroke patients experience chronic arm hand performance problems, compromising independence in daily life activities and quality of life. Traditionally, the effectiveness of reha...
Eligibility Criteria
Inclusion
- Aged between 20-85 year-old
- The onset of stroke must be at least 6 month previously
- The stroke must be the first event
- The stroke must be unilateral brain lesion
- Spasticity measured as Modified Ashworth scale during 1+ to 3
- Score at least 1 point in the wrist subtest of Fugl-Meyer Assessment
- Brunnstrom stage of proximal upper limb at least 3, distal upper limb between 2 to 5
- No impairment in visual tracking ability
- No impairment in proprioception
Exclusion
- Severe joints pain of hand or finger at affected limb
- Fracture of affected limb in three months
- Brunnstrom stage of proximal upper limb not more than 2, distal upper limb more than 5
Key Trial Info
Start Date :
January 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04502264
Start Date
January 9 2020
End Date
February 9 2024
Last Update
March 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cheng-Hsin general hospital
Taipei, Taiwan